Neurologie [Neurology].


Autoria(s): Sokolov A.A.; Rossetti A.O.; Michel P.; Benninger D.; Nater B.; Wider C.; Hirt L.; Kuntzer T.; Démonet J.F.; Du Pasquier R.A.; Vingerhoets F.
Data(s)

2016

Resumo

In 2015, cerebral stimulation becomes increasingly established in the treatment of pharmacoresistant epilepsy. Efficacy of endovascular treatment has been demonstrated for acute ischemic stroke. Deep brain stimulation at low frequency improves dysphagia and freezing of gait in Parkinson patients. Bimagrumab seems to increase muscular volume and force in patients with inclusion body myositis. In cluster-type headache, a transcutaneous vagal nerve stimulator is efficient in stopping acute attacks and also reducing their frequency. Initial steps have been undertaken towards modulating memory by stimulation of the proximal fornix. Teriflunomide is the first oral immunomodulatory drug for which efficacy has been shown in preventing conversion from clinical isolated syndrome to multiple sclerosis.

Identificador

https://serval.unil.ch/?id=serval:BIB_364C4D1D549C

isbn:1660-9379 (Print)

pmid:26946707

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 12, no. 500, pp. 62, 64-62, 66

Tipo

info:eu-repo/semantics/review

article